Dr. Austin Harris pioneers personalized ketamine therapy with 85% success rate for depression, anxiety, PTSD & chronic pain. NeuroRelief offers integrated mentalDr. Austin Harris pioneers personalized ketamine therapy with 85% success rate for depression, anxiety, PTSD & chronic pain. NeuroRelief offers integrated mental

Los Angeles Clinic Reports 85% Success Rate with Personalized Ketamine Therapy Approach

2026/03/03 16:00
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

A medical practice in Los Angeles is reporting an 85% success rate in treating conditions ranging from depression to chronic pain through a personalized approach to ketamine therapy. NeuroRelief Ketamine & Infusion Therapy, founded by Dr. Austin Harris, combines intravenous ketamine treatment with integrative care modalities in what the clinic describes as a ‘one-size-fits-one’ philosophy.

Dr. Harris, a board-certified cardiothoracic anesthesiologist with over 12 years of specialized experience in ketamine treatment, has developed customized programs that integrate IV ketamine therapy with NAD+ infusion therapy and micronutrient infusions. Each treatment plan is tailored to the individual’s unique neurology, psychology, personality, physiology, and specific goals. ‘EVERY single person deserves the right to find relief,’ says Dr. Harris. ‘Our mission is to provide hope and healing to individuals who have struggled to find effective treatment through traditional approaches.’

The practice offers what Dr. Harris calls ‘fully integrated’ care, where every patient works one-on-one with professionals who provide training, guidance, and support in implementing sustainable healing practices. This includes mindfulness meditation, mindful cognitive behavioral therapy exercises, and certified integration and recovery coaching. In an unusual commitment to patient care, Dr. Harris provides all patients with seven-day-a-week real-time access to his personal cell phone, serving as a continuous guide throughout their treatment journey.

Dr. Harris earned his Doctor of Medicine degree, Magna Cum Laude, from St. George’s University School of Medicine and completed his anesthesiology residency at the University of California Irvine. He also completed a fellowship in cardiothoracic anesthesiology at the Keck School of Medicine, USC, and is certified in Psychedelic Integration Therapy and Psychedelic-Assisted Psychotherapy through Fluence. With over a decade of experience in cardiac, thoracic, general, and pediatric anesthesiology, Dr. Harris has served as an attending anesthesiologist at major hospitals across Los Angeles.

Beyond his clinical practice, Dr. Harris is a frequent speaker at national psychedelic medicine and ketamine therapy conferences and has become a leading advocate for the safe, effective, and compassionate use of ketamine in modern medicine. His work bridges traditional medical expertise with integrative healing modalities, encompassing advanced cardiac and thoracic anesthesia, perioperative echocardiography, critical care, and integrative approaches to trauma, addiction, and mood disorders. The practice, located in Sherman Oaks, California, was founded in August 2019 and provides what it describes as a safe, supportive environment where individuals can access cutting-edge therapies combined with compassionate, personalized care.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This news story relied on content distributed by 24-7 Press Release. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Los Angeles Clinic Reports 85% Success Rate with Personalized Ketamine Therapy Approach.

The post Los Angeles Clinic Reports 85% Success Rate with Personalized Ketamine Therapy Approach appeared first on citybuzz.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

The Federal Reserve cut interest rates by 25 basis points, and Powell said this was a risk management cut

The Federal Reserve cut interest rates by 25 basis points, and Powell said this was a risk management cut

PANews reported on September 18th, according to the Securities Times, that at 2:00 AM Beijing time on September 18th, the Federal Reserve announced a 25 basis point interest rate cut, lowering the federal funds rate from 4.25%-4.50% to 4.00%-4.25%, in line with market expectations. The Fed's interest rate announcement triggered a sharp market reaction, with the three major US stock indices rising briefly before quickly plunging. The US dollar index plummeted, briefly hitting a new low since 2025, before rebounding sharply, turning a decline into an upward trend. The sharp market volatility was closely tied to the subsequent monetary policy press conference held by Federal Reserve Chairman Powell. He stated that the 50 basis point rate cut lacked broad support and that there was no need for a swift adjustment. Today's move could be viewed as a risk-management cut, suggesting the Fed will not enter a sustained cycle of rate cuts. Powell reiterated the Fed's unwavering commitment to maintaining its independence. Market participants are currently unaware of the risks to the Fed's independence. The latest published interest rate dot plot shows that the median expectation of Fed officials is to cut interest rates twice more this year (by 25 basis points each), one more than predicted in June this year. At the same time, Fed officials expect that after three rate cuts this year, there will be another 25 basis point cut in 2026 and 2027.
Share
PANews2025/09/18 06:54
SEC Approves Generic Listing Standards for Crypto ETFs

SEC Approves Generic Listing Standards for Crypto ETFs

In a bombshell filing, the SEC is prepared to allow generic listing standards for crypto ETFs. This would permit ETF listings without a specific case-by-case approval process. The filing’s language rests on cryptoassets that are commodities, not securities. However, the Commission is reclassifying many such assets, theoretically enabling an XRP ETF alongside many other new products. Why Generic Listing Standards Matter The SEC has been tacitly approving new crypto ETFs like XRP and DOGE-based products, but there hasn’t been an unambiguously clear signal of greater acceptance. Huge waves of altcoin ETF filings keep reaching the Commission, but there hasn’t been a corresponding show of confidence. Until today, that is, as the SEC just took a sweeping measure to approve generic listing standards for crypto ETFs: “[Several leading exchanges] filed with the SEC proposed rule changes to adopt generic listing standards for Commodity-Based Trust Shares. Each of the foregoing proposed rule changes… were subject to notice and comment. This order approves the Proposals on an accelerated basis,” the SEC’s filing claimed. The proposals came from the Nasdaq, CBOE, and NYSE Arca, which all the ETF issuers have been using to funnel their proposals. In other words, this decision on generic listing standards could genuinely transform crypto ETF approvals. A New Era for Crypto ETFs Specifically, these new standards would allow issuers to tailor-make compliant crypto ETF proposals. If these filings meet all the Commission’s criteria, the underlying ETFs could trade on the market without direct SEC approval. This would remove a huge bottleneck in the coveted ETF creation process. “By approving these generic listing standards, we are ensuring that our capital markets remain the best place in the world to engage in the cutting-edge innovation of digital assets. This approval helps to maximize investor choice and foster innovation by streamlining the listing process,” SEC Chair Paul Atkins claimed in a press release. The SEC has already been working on a streamlined approval process for crypto ETFs, but these generic listing standards could accomplish the task. This rule change would rely on considering tokens as commodities instead of securities, but federal regulators have been reclassifying assets like XRP. If these standards work as advertised, ETFs based on XRP, Solana, and many other cryptos could be coming very soon. This quiet announcement may have huge implications.
Share
Coinstats2025/09/18 06:14
South Korea Halts Trading as Global Markets Plunge

South Korea Halts Trading as Global Markets Plunge

The post South Korea Halts Trading as Global Markets Plunge appeared on BitcoinEthereumNews.com. The Korean Stock Exchange was forced to halt trading after the
Share
BitcoinEthereumNews2026/03/05 07:04